glyburide and glimepiride

glyburide has been researched along with glimepiride in 138 studies

Research

Studies (138)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (0.72)	18.7374
1990's	30 (21.74)	18.2507
2000's	57 (41.30)	29.6817
2010's	44 (31.88)	24.3611
2020's	6 (4.35)	2.80

Authors

Authors	Studies
Grell, W; Griss, G; Hurnaus, R; Luger, P; Mark, M; Müller, P; Nar, H; Rupprecht, E; Sauter, R; Wittneben, H	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Andricopulo, AD; Moda, TL; Montanari, CA	1
Bergström, CA; Hubatsch, I; Johansson, K; Wassvik, CM	1
Lombardo, F; Obach, RS; Waters, NJ	1
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ	1
Caradonna, NP; Hallifax, D; Houston, JB; Turlizzi, E; Zanelli, U	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Aleo, MD; Bonin, PD; Luo, Y; Potter, DM; Swiss, R; Will, Y	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Kume, S; Ozaki, Y; Yatomi, Y	1
Lebrun, P; Malaisse, WJ	1
Akkan, AG; Ledercq-Meyer, V; Malaisse, WJ; Marchand, J	1
Doi, K	1
Geisen, K	1
Mnner, K; Panten, U; Schwanstecher, M	1
Crecelius, A; Müller, G; Pünter, J; Unkelbach, A; Wetekam, EM; Wied, S	1
Hartz, D; Kramer, W; Müller, G; Okonomopulos, R; Pünter, J	1
Girbig, F; Gutjahr, U; Hartz, D; Kowalewski, S; Kramer, W; Müller, G; Summ, HD	2
Lebrun, P; Malaisse, WJ; Sener, A	1
Brasseur, R; Lins, L; Malaisse, WJ	1
Bijlstra, PJ; Lutterman, JA; Russel, FG; Smits, P; Thien, T	1
Draeger, KE; Lomp, HJ; Rosskamp, R; Schüler, E; Wernicke-Panten, K	1
Dills, DG; Schneider, J	1
Clark, HE; Matthews, DR	1
Herz, M; Massi-Benedetti, M; Pfeiffer, C	1
Geisen, K; Kramer, W; Müller, G	1
Geisen, K; Krause, E; Papp, JG; Végh, A	1
Bozdogan, O; Leprán, I; Papp, JG	1
Smits, P	1
Grell, W; Mark, M	1
Fuhlendorff, J; Ladrière, L; Malaisse, WJ; Malaisse-Lagae, F	1
Kaneko, T; Sakamoto, N	1
Brogard, JM	1
Rocchetti, M; Rosati, B; Wanke, E; Zaza, A	1
Baczkó, I; Bozdogan, O; El-Reyani, NE; Leprán, I; Papp, JG	1
Amann, FW; Boedeker, KH; Burger, W; Gruber, D; Harris, S; Kiowski, W; Klepzig, H; Kober, G; Luus, H; Matter, C; Schneider, H	1
Dimitriadis, G; Draeger, KE; Hatziagelaki, E; Pfeiffer, C; Raptis, AE; Raptis, SA	1
Henke, B; Lindner, S; Müller, M; Mutschler, E; Olbrich, HG; Oremek, G; Riehle, M; Zarse, M	1
Riddle, M	1
Baczkó, I; El-Reyani, NE; Leprán, I; Papp, JG	1
Filipiak, KJ	1
Brunelli, C; Cordera, R; Cordone, S; Olivotti, L; Rossettin, P; Schiavo, M; Spallarossa, P	1
Houston, RJ; Legtenberg, RJ; Oeseburg, B; Smits, P	1
Baxter, GF; Lawrence, CL; Maddock, HL; Mocanu, MM; Standen, NB; Yellon, DM	1
Abbink, EJ; Jansen van Rosendaal, A; Lutterman, JA; Pickkers, P; Russel, FG; Smits, P; Tack, CJ	1
Hu, S	1
Kocsis, E; Koltai, MZ; Nieszner, E; Pogátsa, G; Pósa, I	1
Cascorbi, I; Kivistö, KT; Kroemer, HK; Neuvonen, PJ; Niemi, M; Timm, R	1
Nakamura, N	1
Bachmann, O; Dahl, D; Häring, HU; Haupt, A; Kausch, C; Matthaei, S; Stumvoll, M	1
Chou, TF; Lee, TM	1
Auclair, J; Bouskela, E; Félétou, M; Levens, N; Néliat, G; Ravel, D	1
Egberts, EH; Hammer, C; Holstein, A; Plaschke, A	1
Bataille, D	1
Beuth, J; Kolb, H; Martin, S; Scherbaum, WA; Schneider, B; van Leendert, R	1
Komiya, H; Kurokawa, N; Mori, Y; Tajima, N	1
Clifton-Bligh, RJ; Veitch, PC	1
Riddle, MC	1
Abe, Y; Matsumoto, K; Miyake, S; Sera, Y; Tominaga, T; Yeki, Y	1
Fukuen, S; Iwaki, M; Makishima, M; Matsuda, M; Shimomura, I; Yasui, A	1
Awata, T; Inukai, K; Kashiwabara, H; Katayama, S; Kurihara, S; Nakashima, Y; Sawa, T; Suzuki, M; Takata, N; Tanaka, M; Watanabe, M; Yokota, K	1
Charpentier, G; Clerson, P; Dubroca, I; Fleury, F; Vaur, L	1
Brockmöller, J; Egberts, EH; El-Din, J; Holstein, A; Kirchheiner, J; Plaschke, A; Ptak, M	1
Martin, S	1
Hashimoto, S; Ishikawa, SE; Kawakami, M; Kuroki, M; Saito, M; Ueba, H; Umemoto, T; Yasu, T	1
Cryer, PE; Fender, AB; Gerich, JE; Gosmanov, NR; Meyer, C; Nihalani, A; Sinkin, JC; Szoke, E	1
Hashizume, K; Komatsu, M	1
Kobayashi, K; Kobayashi, M; Kojima, M; Maruyama, I; Maruyama, K; Ojima, K; Shibata, N; Tomiyama, Y; Yamazaki, Y	1
Ito, S; Koshiba, K; Nakaya, Y; Nomura, M	1
Aoyagi, I; Fujimori, Y; Fuujimori, Y; Itoh, Y; Kojima, M; Kojima, S; Kusama, H; Mori, Y; Ojima, K; Shibata, N; Tajima, N; Yamazaki, Y	1
El Deeb, S; Schepers, U; Wätzig, H	1
Hashimoto, Y; Iwakawa, S; Kuroda, T; Miyashita, K	1
El Deeb, S; Preu, L; Wätzig, H	1
Jin, SH; Li, ZR; Shi, YQ; Yao, J	1
Kimura, T; Kita, M; Suzuma, K; Takagi, H; Watanabe, D; Yoshimura, N	1
Chakradhar, L; Kallem, R; Karthik, A; Mullangi, R; Ramesh, S; Srinivas, NR; Sundari, BT	1
Basu, A; Basu, R; Charkoudian, N; Joyner, MJ; Rizza, RA; Schrage, W	1
Bhattacharya, SK; Das, BP; Madhu, SV; Mahajan, P; Paudel, KR; Rauniar, GP; Shastri, S; Tripathi, AK	1
Li, J; Wang, L; Wu, GT; Zhu, WZ	1
Krishnarajah, G; Lyu, R; Mavros, P; Vexiau, P; Yin, D	1
El Deeb, S; Kaminski, L; Wätzig, H	1
Hattori, Y; Hirama, N; Jojima, T; Suzuki, K; Uchida, K	1
Fujii, M; Inoguchi, T; Kobayashi, K; Maeda, Y; Morinaga, H; Nomura, M; Sasaki, S; Sawada, F; Takayanagi, R; Tsubouchi, H	1
Tayek, J	1
Birnbaum, Y; Lin, Y; Perez-Polo, JR; Ye, Y	1
Argaud, L; Couture-Lepetit, E; Garrier, O; Gateau-Roesch, O; Gomez, L; Loufouat, J; Ovize, M; Robert, D	1
Khalangot, M; Kovtun, V; Kravchenko, V; Tronko, M	1
Ee, JW; Kwon, SW; Lee, J; Lee, WJ; Park, JH; Shaodong, J	1
Du, W; Huang, QX; Liu, L; Liu, YH; Xie, XM; Xu, DY; Zhao, SP	1
Böhm, R; Cascorbi, I; Herdegen, T	1
Arai, K; Hirao, K; Kanamori, A; Matoba, K; Matsuba, I; Mori, H; Takai, M; Takeda, H; Terauchi, Y; Yamauchi, M	1
Arrigain, S; Atreja, A; Jain, A; Kattan, MW; Pantalone, KM; Wells, BJ; Yu, C; Zimmerman, RS	2
Hahn, M; Hammer, C; Holstein, A; Kovacs, P; Kulamadayil, NS	1
Bełtowski, J; Jamroz-Wiśniewska, A; Marciniak, A; Wójcicka, G; Łowicka, E	1
Heikkilä, P; Huupponen, R; Laine, K; Tirkkonen, T	1
Ban, N; Endo, K; Kawana, H; Miyashita, Y; Nagayama, D; Ohira, M; Oyama, T; Saiki, A; Shirai, K; Yamaguchi, T	1
Kaneto, H; Katakami, N; Matsuhisa, M; Shimomura, I; Yamasaki, Y	1
Bhavsar, DD; Charakida, M; Deanfield, JE; Loukogeorgakis, SP; MacAllister, RJ; Okorie, MI; Ridout, D	1
Kara, M; Proschak, E; Schneider, G; Schubert-Zsilavecz, M; Steinhilber, D; Steri, R	1
Celner, J; Enzmann, H; Haas, B; Mayer, P; Pfeifer, A	1
Andersson, C; Gislason, GH; Hansen, PR; Jørgensen, CH; Køber, L; Mérie, C; Norgaard, ML; Olesen, JB; Schmiegelow, M; Sørensen, R; Torp-Pedersen, C; Vaag, A; Weeke, P	1
Burns, BD; Levine, M; Lovecchio, F; Pizon, AF; Riley, BD; Ruha, AM; Thomas, SH	1
Abdelmoneim, AS; Brocks, DR; Hasenbank, SE; Light, PE; Seubert, JM; Simpson, SH	1
Bernhardt, R; Hannemann, F; Hutter, M; Kleser, M; Zapp, J	1
Fatehi, M; Lang, VY; Light, PE	1
Arrigain, S; Atreja, A; Jain, A; Kattan, MW; Nutter, B; Pantalone, KM; Wells, BJ; Yu, C; Zimmerman, RS	1
Dyrskjøt, L; Grimm, D; Magnusson, NE; Pietsch, J; Rungby, J; Wehland, M	1
Bader, G; Dworak, M; Giani, G; Gruenberger, JB; Kostev, K; Rathmann, W	1
Kimura, H; Masuda, S; Sato, D; Sato, Y	1
Bruce, SS; Connolly, ES; Heyer, EJ; Mergeche, JL	1
Chang, MP; Chen, CC; Hung, YC; Lin, CC; Sung, FC; Wang, TY	1
Andersson, C; Fosbøl, EL; Gislason, G; Køber, L; Mogensen, UM; Scheller, NM; Schramm, TK; Torp-Pedersen, C; Vaag, A	1
Davis, SN; Joy, NG; Tate, DB	1
Bilker, WB; Brensinger, CM; Cardillo, S; Flockhart, DA; Flory, JH; Gagne, JJ; Han, X; Hennessy, S; Leonard, CE	1
Ito, R; Matsuda, K; Miyawaki, K; Suzuki, M; Takeuchi, K; Tsujihata, Y	1
Kuwata, H; Seino, Y; Yabe, D	1
Ali, Z; Daniyal, M; Naveed, S; S I, I; Usmanghani, K	1
Bilker, WB; Brensinger, CM; Chiang, C; Han, X; Hennessy, S; Leonard, CE; Li, L	1
Bellone, JM; Ruhland, DJ; Wilkes, E	1
Aquilante, CL; Bilker, WB; Boudreau, DM; Brensinger, CM; Deo, R; Flory, JH; Gagne, JJ; Hennessy, S; Leonard, CE; Mangaali, MJ	1
Chen, SH; Liu, XN; Peng, Y; Sun, QY	1
Dong, J; Liao, L; Shen, X; Xie, T; Xu, C; Zhang, R; Zhou, X; Zou, Z	1
Huang, HK; Yeh, JI	1
Bahtiri, E; Begolli, L; Blaslov, K; Car, N; Emini-Sadiku, M; Haliti, E	1
Bilker, WB; Brensinger, CM; Dawwas, GK; Dhopeshwarkar, N; Flory, JH; Gagne, JJ; Hennessy, S; Leonard, CE; Soprano, SE	1
Chiriac, FL; Iancu, VI; Radu, GL; Scutariu, RE	1
Bilker, WB; Brensinger, CM; Flory, JH; Hee Nam, Y; Hennessy, S; Leonard, CE	1
Berry, SD; Hayes, KN; Munshi, MN; Riester, MR; Zullo, AR	1
Gayakvad, B; Kothari, C; Patel, C; Patel, R; Solanki, R; Wadhwana, P	1
Jannetto, PJ; Langman, LJ	1

Reviews

17 review(s) available for glyburide and glimepiride

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
The molecular interaction of sulfonylureas with beta-cell ATP-sensitive K(+)-channels. Diabetes research and clinical practice, 1995, Volume: 28 Suppl Topics: Adenosine Triphosphate; Affinity Labels; Animals; ATP-Binding Cassette Transporters; Binding, Competitive; Cell Line; Cell Membrane; Glyburide; Humans; Hypoglycemic Agents; Islets of Langerhans; Kinetics; Models, Biological; Pancreatic Neoplasms; Potassium Channels; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Sulfonylurea Compounds; Sulfonylurea Receptors	1995
Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at beta-cells. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1996, Volume: 28, Issue:9 Topics: Animals; ATP-Binding Cassette Transporters; Cell Membrane; Glucose; Glyburide; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Potassium Channels; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Sulfonylurea Compounds; Sulfonylurea Receptors	1996
Cardiovascular effects of sulphonylurea derivatives. Diabetologia, 1997, Volume: 40 Suppl 2 Topics: Adenosine Triphosphate; Animals; Cardiovascular System; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic Agents; Potassium Channels; Sulfonylurea Compounds	1997
[Clinical efficacy of glimepiride]. Nihon rinsho. Japanese journal of clinical medicine, 1997, Volume: 55 Suppl Topics: Blood Glucose; Diabetes Mellitus, Type 2; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Sulfonylurea Compounds; Vascular Resistance	1997
Combining sulfonylureas and other oral agents. The American journal of medicine, 2000, Apr-17, Volume: 108 Suppl 6a Topics: Acarbose; Administration, Oral; Carbamates; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glyburide; Humans; Hypoglycemic Agents; Metformin; Piperidines; Sulfonylurea Compounds	2000
[Sulphonylurea derivatives and the cardiovascular system]. Przeglad lekarski, 2000, Volume: 57 Suppl 4 Topics: Animals; Cardiovascular System; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic Agents; Potassium Channels; Sulfonylurea Compounds	2000
[Glimepiride]. Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 9 Topics: Adenosine Triphosphate; Animals; ATP-Binding Cassette Transporters; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic Agents; Insulin Resistance; Potassium Channels; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Sulfonylurea Compounds; Sulfonylurea Receptors	2002
[Molecular mechanisms of insulin secretion]. Diabetes & metabolism, 2002, Volume: 28, Issue:6 Suppl Topics: Animals; Calcium Signaling; Exocytosis; Glyburide; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Models, Biological; Potassium; Potassium Channels; Sulfonylurea Compounds	2002
Long-acting sulfonylureas -- long-acting hypoglycaemia. The Medical journal of Australia, 2004, Jan-19, Volume: 180, Issue:2 Topics: Aged; Aged, 80 and over; Blood Glucose; Diabetes Mellitus, Type 2; Drug Monitoring; Fatal Outcome; Female; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Sulfonylurea Compounds	2004
Timely initiation of basal insulin. The American journal of medicine, 2004, Feb-02, Volume: 116 Suppl 3A Topics: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Disease Progression; Drug Therapy, Combination; Glyburide; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin, Long-Acting; Postprandial Period; Sulfonylurea Compounds	2004
[Retrolective study design -- a new tool of evidence-based medicine]. Deutsche medizinische Wochenschrift (1946), 2005, Jul-08, Volume: 130 Suppl 2 Topics: Blood Glucose; Blood Glucose Self-Monitoring; Body Weight; Cohort Studies; Diabetes Mellitus, Type 2; Evidence-Based Medicine; Glyburide; Humans; Hypoglycemic Agents; Observation; Prospective Studies; Randomized Controlled Trials as Topic; Reproducibility of Results; Sulfonylurea Compounds	2005
[Knack of treatment with oral hypoglycemic drugs in the elderly]. Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64, Issue:1 Topics: Aged; Biguanides; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Sulfonylurea Compounds; Thiazolidinediones	2006
[Hypoglycemic risk of insulinotropic drugs]. Medizinische Monatsschrift fur Pharmazeuten, 2009, Volume: 32, Issue:12 Topics: Blood Glucose; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Risk; Sulfonylurea Compounds	2009
Variations in tissue selectivity amongst insulin secretagogues: a systematic review. Diabetes, obesity & metabolism, 2012, Volume: 14, Issue:2 Topics: Animals; ATP-Binding Cassette Transporters; Carbamates; Cardiovascular Diseases; Cricetinae; Cyclohexanes; Diabetes Mellitus, Type 2; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Ischemic Preconditioning, Myocardial; Isoindoles; Mice; Muscle, Smooth, Vascular; Myocytes, Cardiac; Nateglinide; Phenylalanine; Piperidines; Potassium Channels, Inwardly Rectifying; Rats; Receptors, Drug; Risk Factors; Sulfonylurea Compounds; Sulfonylurea Receptors; Tolbutamide	2012
Incretin-based drugs for type 2 diabetes: Focus on East Asian perspectives. Journal of diabetes investigation, 2016, Volume: 7 Suppl 1 Topics: Animals; Asian People; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide-1 Receptor; Glucose; Glucose Tolerance Test; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Incretins; Insulin; Insulin Resistance; Insulin Secretion; Mice; Rats; Risk Factors; Sulfonylurea Compounds; Treatment Outcome	2016
Efficacy of different antidiabetic drugs based on metformin in the treatment of type 2 diabetes mellitus: A network meta-analysis involving eight eligible randomized-controlled trials. Journal of cellular physiology, 2019, Volume: 234, Issue:3 Topics: Blood Glucose; Diabetes Mellitus, Type 2; Drug Combinations; Exenatide; Female; Glyburide; Humans; Male; Metformin; Network Meta-Analysis; Pioglitazone; Randomized Controlled Trials as Topic; Rosiglitazone; Sulfonylurea Compounds; Vildagliptin	2019

Trials

18 trial(s) available for glyburide and glimepiride

Article	Year
Interaction of sulphonylurea derivatives with vascular ATP-sensitive potassium channels in humans. Diabetologia, 1996, Volume: 39, Issue:9 Topics: Adult; Analysis of Variance; Blood Pressure; Diazoxide; Forearm; Glyburide; Humans; Hypoglycemic Agents; Injections, Intra-Arterial; Male; Muscle, Smooth, Vascular; Nitroprusside; Potassium Channels; Reference Values; Regional Blood Flow; Sulfonylurea Compounds; Vasodilation; Vasodilator Agents	1996
Long-term treatment of type 2 diabetic patients with the new oral antidiabetic agent glimepiride (Amaryl): a double-blind comparison with glibenclamide. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1996, Volume: 28, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Prospective Studies; Sulfonylurea Compounds	1996
Clinical evaluation of glimepiride versus glyburide in NIDDM in a double-blind comparative study. Glimepiride/Glyburide Research Group. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1996, Volume: 28, Issue:9 Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Sulfonylurea Compounds	1996
The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1996, Volume: 28, Issue:9 Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Glucose Clamp Technique; Glyburide; Humans; Hyperglycemia; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Placebos; Sulfonylurea Compounds	1996
The effects of acute exercise on metabolic control in type II diabetic patients treated with glimepiride or glibenclamide. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1996, Volume: 28, Issue:9 Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Exercise; Female; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Sulfonylurea Compounds	1996
Sulfonylureas and ischaemic preconditioning; a double-blind, placebo-controlled evaluation of glimepiride and glibenclamide. European heart journal, 1999, Volume: 20, Issue:6 Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Coronary Disease; Double-Blind Method; Electrocardiography; Female; Glyburide; Humans; Hypoglycemic Agents; Injections, Intravenous; Ischemic Preconditioning; Male; Middle Aged; Sulfonylurea Compounds; Treatment Outcome	1999
Comparative effects of glimepiride and glibenclamide on blood glucose, C-peptide and insulin concentrations in the fasting and postprandial state in normal man. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 1999, Volume: 107, Issue:6 Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Cross-Over Studies; Double-Blind Method; Fasting; Food; Glyburide; Humans; Hypoglycemic Agents; Insulin; Kinetics; Male; Middle Aged; Placebos; Sulfonylurea Compounds	1999
Sulfonylurea treatment of type 2 diabetic patients does not reduce the vasodilator response to ischemia. Diabetes care, 2001, Volume: 24, Issue:4 Topics: Aged; Aged, 80 and over; Blood Pressure; Brachial Artery; Diabetes Mellitus, Type 2; Diet, Diabetic; Female; Forearm; Gliclazide; Glyburide; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Ischemia; Male; Metformin; Middle Aged; Reference Values; Regional Blood Flow; Sulfonylurea Compounds; Ultrasonography	2001
Vascular effects of glibenclamide vs. glimepiride and metformin in Type 2 diabetic patients. Diabetic medicine : a journal of the British Diabetic Association, 2002, Volume: 19, Issue:2 Topics: Acetylcholine; Adult; Aged; Blood Flow Velocity; Blood Pressure; Body Mass Index; Body Weight; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Diazoxide; Dipyridamole; Double-Blind Method; Female; Forearm; Glyburide; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Sulfonylurea Compounds; Vasodilation	2002
Change in patients' body weight after 12 months of treatment with glimepiride or glibenclamide in Type 2 diabetes: a multicentre retrospective cohort study. Diabetologia, 2003, Volume: 46, Issue:12 Topics: Blood Glucose; Body Mass Index; Body Weight; Cholesterol; Cohort Studies; Diabetes Mellitus, Type 2; Female; Germany; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Retrospective Studies; Sulfonylurea Compounds; Time Factors; Treatment Outcome; Triglycerides	2003
Efficacy of glimepiride in Japanese type 2 diabetic subjects. Diabetes research and clinical practice, 2005, Volume: 68, Issue:3 Topics: Aged; Asian People; Body Mass Index; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Gliclazide; Glyburide; Glycated Hemoglobin; Homeostasis; Humans; Hypoglycemic Agents; Insulin Resistance; Logistic Models; Male; Middle Aged; Obesity; Retreatment; Sulfonylurea Compounds; Treatment Outcome	2005
Electronic pill-boxes in the evaluation of oral hypoglycemic agent compliance. Diabetes & metabolism, 2005, Volume: 31, Issue:2 Topics: Adult; Aged; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Monitoring; Drug Packaging; Electronics, Medical; Female; France; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Middle Aged; Patient Compliance; Patient Satisfaction; Sulfonylurea Compounds	2005
Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia. Metabolism: clinical and experimental, 2006, Volume: 55, Issue:1 Topics: Adult; Blood Glucose; C-Peptide; Epinephrine; Female; Glucose; Glyburide; Hormones; Human Growth Hormone; Humans; Hydrocortisone; Hypoglycemia; Hypoglycemic Agents; Insulin; Kinetics; Male; Sulfonylurea Compounds	2006
Efficacy of glimepiride on insulin resistance, adipocytokines, and atherosclerosis. The journal of medical investigation : JMI, 2006, Volume: 53, Issue:1-2 Topics: Adipocytes; Aged; Atherosclerosis; Cytokines; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hypoglycemic Agents; Inflammation Mediators; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Sulfonylurea Compounds	2006
Beneficial effects of GLP-1 on endothelial function in humans: dampening by glyburide but not by glimepiride. American journal of physiology. Endocrinology and metabolism, 2007, Volume: 293, Issue:5 Topics: Acetylcholine; Adult; Blood Glucose; C-Reactive Protein; Drug Interactions; Endothelium, Vascular; Female; Forearm; Glucagon-Like Peptide 1; Glyburide; Humans; Hypoglycemic Agents; Incretins; Insulin; Male; Nitroprusside; Plethysmography; Regional Blood Flow; Sulfonylurea Compounds; Vasodilator Agents	2007
Improvement of cardio-ankle vascular index by glimepiride in type 2 diabetic patients. International journal of clinical practice, 2010, Volume: 64, Issue:13 Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Ankle; Deoxyguanosine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipids; Male; Middle Aged; Sulfonylurea Compounds; Vascular Resistance; Vascular Stiffness	2010
Counterregulatory responses to hypoglycemia differ between glimepiride and glyburide in non diabetic individuals. Metabolism: clinical and experimental, 2015, Volume: 64, Issue:6 Topics: Adult; Blood Glucose; C-Peptide; Female; Glucagon; Glucose Clamp Technique; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Leptin; Male; Pancreatic Polypeptide; Single-Blind Method; Sulfonylurea Compounds	2015
The differential influence of glimepiride and glibenclamide on insulin resistance and adiponectin levels in patients with type 2 diabetes. Endocrine journal, 2019, Oct-28, Volume: 66, Issue:10 Topics: Adiponectin; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Middle Aged; Prospective Studies; Sulfonylurea Compounds	2019

Other Studies

103 other study(ies) available for glyburide and glimepiride

Article	Year
Repaglinide and related hypoglycemic benzoic acid derivatives. Journal of medicinal chemistry, 1998, Dec-17, Volume: 41, Issue:26 Topics: Administration, Oral; Animals; ATP-Binding Cassette Transporters; Benzoates; Blood Glucose; Carbamates; Crystallography, X-Ray; Female; Glyburide; Hypoglycemic Agents; Models, Molecular; Molecular Conformation; Piperidines; Potassium Channels; Potassium Channels, Inwardly Rectifying; Rats; Rats, Wistar; Receptors, Drug; Stereoisomerism; Structure-Activity Relationship; Sulfonylurea Compounds; Sulfonylurea Receptors	1998
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Hologram QSAR model for the prediction of human oral bioavailability. Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24 Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2007
Poorly soluble marketed drugs display solvation limited solubility. Journal of medicinal chemistry, 2007, Nov-15, Volume: 50, Issue:23 Topics: Calorimetry, Differential Scanning; Chemical Phenomena; Chemistry, Physical; Chromatography, High Pressure Liquid; Molecular Structure; Multivariate Analysis; Pharmaceutical Preparations; Principal Component Analysis; Solubility; Tandem Mass Spectrometry; Thermodynamics	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2). Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11 Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics	2010
Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:1 Topics: Cell Line, Tumor; Cryopreservation; Female; Hepatocytes; Humans; Male; Metabolic Clearance Rate; Pharmaceutical Preparations; Predictive Value of Tests	2012
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump. Hepatology (Baltimore, Md.), 2014, Volume: 60, Issue:3 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; Humans; Male; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Severity of Illness Index	2014
Effects of oral hypoglycaemic agents on platelet functions. Biochemical pharmacology, 1992, Aug-18, Volume: 44, Issue:4 Topics: Arachidonic Acid; Calcium; Dose-Response Relationship, Drug; Fura-2; Gliclazide; Glyburide; Humans; Ionomycin; Platelet Activation; Platelet Aggregation Inhibitors; Sulfonylurea Compounds	1992
Cationic and secretory effects of glimepiride and glibenclamide in perifused rat islets. Pharmacology & toxicology, 1992, Volume: 70, Issue:5 Pt 1 Topics: Animals; Calcium Radioisotopes; Glyburide; Hypoglycemic Agents; In Vitro Techniques; Insulin; Islets of Langerhans; Perfusion; Rats; Rubidium Radioisotopes; Sulfonylurea Compounds	1992
Effects of glimepiride and glibenclamide on insulin and glucagon secretion by the perfused rat pancreas. Biochemical pharmacology, 1991, Sep-27, Volume: 42, Issue:8 Topics: Animals; Female; Glucagon; Glyburide; Hypoglycemic Agents; Insulin; Insulin Secretion; Pancreas; Perfusion; Rats; Rats, Inbred Strains; Sulfonylurea Compounds; Time Factors	1991
[New oral antidiabetic agents]. Nihon rinsho. Japanese journal of clinical medicine, 1990, Volume: 48 Suppl Topics: Animals; Cyclohexanols; Diabetes Mellitus; Drug Evaluation; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Imidazoles; Insulin; Insulin Secretion; Molecular Structure; Pyrrolidines; Stimulation, Chemical; Sulfonylurea Compounds	1990
Special pharmacology of the new sulfonylurea glimepiride. Arzneimittel-Forschung, 1988, Volume: 38, Issue:8 Topics: Administration, Oral; Animals; Blood Glucose; Chemical Phenomena; Chemistry; Dogs; Female; Glucagon; Glucose; Glyburide; Hypoglycemic Agents; Injections, Intravenous; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Lactates; Male; Pancreas; Rabbits; Rats; Somatostatin; Sulfonylurea Compounds	1988
Inhibition of K+ channels and stimulation of insulin secretion by the sulfonylurea, glimepiride, in relation to its membrane binding in pancreatic islets. Pharmacology, 1994, Volume: 49, Issue:2 Topics: Animals; Electrophysiology; Glyburide; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Mice; Microsomes; Potassium Channels; Sulfonylurea Compounds	1994
Stimulation of glucose utilization in 3T3 adipocytes and rat diaphragm in vitro by the sulphonylureas, glimepiride and glibenclamide, is correlated with modulations of the cAMP regulatory cascade. Biochemical pharmacology, 1994, Aug-30, Volume: 48, Issue:5 Topics: 3T3 Cells; Adipocytes; Animals; Biological Transport; Cyclic AMP; Diaphragm; Enzymes; Glucose; Glyburide; Glycogen; Lipids; Male; Mice; Rats; Rats, Wistar; Sulfonylurea Compounds	1994
Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. I. Binding characteristics. Biochimica et biophysica acta, 1994, May-11, Volume: 1191, Issue:2 Topics: Animals; ATP-Binding Cassette Transporters; Cell Line; Cell Membrane; Diabetes Mellitus, Type 2; Glyburide; Hypoglycemic Agents; Kinetics; Pancreas; Potassium Channels; Potassium Channels, Inwardly Rectifying; Rats; Receptors, Drug; Sulfonylurea Compounds; Sulfonylurea Receptors; Tritium	1994
Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. II. Photoaffinity labeling of a 65 kDa protein by [3H]glimepiride. Biochimica et biophysica acta, 1994, May-11, Volume: 1191, Issue:2 Topics: Affinity Labels; Animals; ATP-Binding Cassette Transporters; Binding Sites; Carrier Proteins; Cell Line; Cell Membrane; Glyburide; Hypoglycemic Agents; Pancreas; Potassium Channels; Potassium Channels, Inwardly Rectifying; Rats; Receptors, Drug; Structure-Activity Relationship; Sulfonylurea Compounds; Sulfonylurea Receptors; Tritium	1994
Modulation of the insulinotropic action of glibenclamide and glimepiride by nutrient secretagogues in pancreatic islets from normoglycemic and hyperglycemic rats. Biochemical pharmacology, 1993, May-05, Volume: 45, Issue:9 Topics: Animals; B-Lymphocytes; Calcium; Carbon Dioxide; Diabetes Mellitus, Type 2; Glucose; Glyburide; Hyperglycemia; In Vitro Techniques; Insulin; Islets of Langerhans; Perfusion; Rats; Succinates; Sulfonylurea Compounds; Water	1993
Conformational analysis of non-sulfonylurea hypoglycemic agents of the meglitinide family. Biochemical pharmacology, 1995, Nov-27, Volume: 50, Issue:11 Topics: Benzamides; Carbamates; Cyclohexanes; Drug Design; Glyburide; Hypoglycemic Agents; Indoles; Isoindoles; Molecular Conformation; Nateglinide; Phenylalanine; Piperidines; Stereoisomerism; Structure-Activity Relationship; Sulfonylurea Compounds	1995
Cardiovascular effects of conventional sulfonylureas and glimepiride. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1996, Volume: 28, Issue:9 Topics: Animals; Blood Pressure; Cardiovascular System; Coronary Vessels; Diabetes Mellitus, Experimental; Dogs; Electrocardiography; Female; Gliclazide; Glyburide; Hypoglycemic Agents; Male; Myocardial Ischemia; Potassium Channels; Rats; Rats, Wistar; Sulfonylurea Compounds	1996
Effect of glimepiride and glibenclamide, inhibitors of ATP-dependent K(+)-channel, on ischaemia-reperfusion induced arrhythmias in rats. Acta physiologica Hungarica, 1996, Volume: 84, Issue:3 Topics: Adenosine Triphosphate; Animals; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Glyburide; Heart; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley; Sulfonylurea Compounds; Survival Analysis	1996
Hypoglycaemic effects of the novel antidiabetic agent repaglinide in rats and dogs. British journal of pharmacology, 1997, Volume: 121, Issue:8 Topics: Animals; Carbamates; Dogs; Female; Glyburide; Hypoglycemic Agents; Piperidines; Rats; Rats, Wistar; Stereoisomerism; Sulfonylurea Compounds	1997
Repaglinide, glibenclamide and glimepiride administration to normal and hereditarily diabetic rats. European journal of pharmacology, 1997, Sep-24, Volume: 335, Issue:2-3 Topics: Administration, Oral; Animals; Blood Glucose; Carbamates; Diabetes Mellitus, Type 2; Fasting; Female; Glyburide; Hypoglycemic Agents; Insulin; Male; Piperidines; Rats; Rats, Wistar; Sulfonylurea Compounds	1997
[24 years later....]. La Revue de medecine interne, 1998, Volume: 19, Issue:10 Topics: Cell Membrane; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic Agents; Patch-Clamp Techniques; Sulfonylurea Compounds	1998
Sulfonylureas blockade of neural and cardiac HERG channels. FEBS letters, 1998, Nov-27, Volume: 440, Issue:1-2 Topics: Action Potentials; Animals; Cation Transport Proteins; Chromans; DNA-Binding Proteins; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Glyburide; Guinea Pigs; Humans; Inhibitory Concentration 50; Mice; Myocardium; Neuroblastoma; Neurons; Nisoldipine; Piperidines; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Pyridines; Rats; Sulfonamides; Sulfonylurea Compounds; Trans-Activators; Transcriptional Regulator ERG; Tumor Cells, Cultured	1998
Comparison of the efficacy of glibenclamide and glimepiride in reperfusion-induced arrhythmias in rats. European journal of pharmacology, 1999, Jan-22, Volume: 365, Issue:2-3 Topics: Anesthesia; Animals; Arrhythmias, Cardiac; Blood Glucose; Blood Pressure; Coronary Vessels; Glyburide; Hypoglycemic Agents; Ligation; Male; Myocardial Reperfusion Injury; Rats; Rats, Sprague-Dawley; Sulfonylurea Compounds; Survival Rate	1999
Glimepiride (Hoe490) inhibits the rilmakalim induced decrease in intracellular free calcium and contraction of isolated heart muscle cells from guinea pigs to a lesser extent than glibenclamide. International journal of cardiology, 1999, Dec-15, Volume: 72, Issue:1 Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Calcium; Chromans; Glyburide; Guinea Pigs; Hypoglycemic Agents; In Vitro Techniques; Myocardial Contraction; Potassium; Potassium Channels; Pyrrolidines; Sulfonylurea Compounds	1999
Effect of glibenclamide and glimepiride treatment on the development of myocardial infarction in rats. Acta physiologica Hungarica, 2000, Volume: 87, Issue:2 Topics: Animals; Coronary Vessels; Glyburide; Heart Ventricles; Hypoglycemic Agents; Image Processing, Computer-Assisted; Ligation; Male; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Sulfonylurea Compounds; Survival Analysis	2000
Effects of sulfonylurea derivatives on ischemia-induced loss of function in the isolated rat heart. European journal of pharmacology, 2001, May-04, Volume: 419, Issue:1 Topics: Animals; Anti-Arrhythmia Agents; Coronary Circulation; Dose-Response Relationship, Drug; Glyburide; Heart; In Vitro Techniques; Male; Myocardial Stunning; Rats; Rats, Wistar; Sulfonylurea Compounds	2001
Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide. Circulation, 2001, Jun-26, Volume: 103, Issue:25 Topics: Animals; Diazoxide; Glyburide; Guanosine Triphosphate; Heart; Heart Ventricles; Hemodynamics; Hypoglycemic Agents; In Vitro Techniques; Intracellular Membranes; Ischemic Preconditioning, Myocardial; Male; Membrane Potentials; Membrane Proteins; Mitochondria, Heart; Myocardial Infarction; Myocardial Ischemia; Patch-Clamp Techniques; Potassium Channels; Rats; Rats, Sprague-Dawley; Sulfonylurea Compounds; Ventricular Function	2001
Interaction of nateglinide with K(ATP) channel in beta-cells underlies its unique insulinotropic action. European journal of pharmacology, 2002, May-03, Volume: 442, Issue:1-2 Topics: Adenosine Triphosphate; Animals; Carbamates; Cyclohexanes; Dose-Response Relationship, Drug; Glucose; Glyburide; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Male; Membrane Potentials; Nateglinide; Phenylalanine; Piperidines; Potassium Channel Blockers; Potassium Channels; Rats; Rats, Sprague-Dawley; Sulfonylurea Compounds; Time Factors	2002
Haemodynamic and metabolic effects of low daily dose sulphonylureas in diabetic dog hearts. Arzneimittel-Forschung, 2002, Volume: 52, Issue:7 Topics: Animals; Blood Glucose; Blood Pressure; Coronary Circulation; Diabetes Mellitus, Experimental; Dogs; Female; Glyburide; Heart; Heart Rate; Hemodynamics; Hypoglycemic Agents; Lactic Acid; Male; Myocardial Contraction; Potassium; Pyruvic Acid; Sulfonylurea Compounds	2002
Glyburide and glimepiride pharmacokinetics in subjects with different CYP2C9 genotypes. Clinical pharmacology and therapeutics, 2002, Volume: 72, Issue:3 Topics: Adult; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Blood Glucose; Cytochrome P-450 CYP2C9; Cytochrome P-450 Enzyme System; Female; Genotype; Glyburide; Humans; Hypoglycemic Agents; Male; Polymorphism, Genetic; Statistics, Nonparametric; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Sulfonylurea Compounds	2002
Effect of glimepiride on insulin-stimulated glycogen synthesis in cultured human skeletal muscle cells: a comparison to glibenclamide. Diabetes care, 2002, Volume: 25, Issue:12 Topics: Androstadienes; Cell Culture Techniques; Cells, Cultured; Diabetes Mellitus, Type 2; Female; Glyburide; Glycogen; Humans; Hypoglycemic Agents; Insulin; Kinetics; Male; Muscle, Skeletal; Sulfonylurea Compounds; Wortmannin	2002
Impairment of myocardial protection in type 2 diabetic patients. The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Blood Pressure; Chest Pain; Diabetes Mellitus, Type 2; Electrocardiography; Female; Glyburide; Heart Rate; Humans; Hypoglycemic Agents; Ischemic Preconditioning; Lactic Acid; Male; Middle Aged; Myocardial Ischemia; Nicorandil; Potassium Channels; Prospective Studies; Sulfonylurea Compounds; Vasodilator Agents	2003
Differential effects of sulphonylureas on the vasodilatory response evoked by K(ATP) channel openers. Fundamental & clinical pharmacology, 2003, Volume: 17, Issue:1 Topics: Adenosine Triphosphate; Animals; Aorta, Thoracic; Cricetinae; Cromakalim; Diazoxide; Drug Interactions; Gliclazide; Glyburide; Guinea Pigs; Hypoglycemic Agents; In Vitro Techniques; Ion Channel Gating; Male; Potassium Channels; Rats; Rats, Wistar; Species Specificity; Sulfonylurea Compounds; Vasodilation; Vasodilator Agents	2003
Characteristics and time course of severe glimepiride- versus glibenclamide-induced hypoglycaemia. European journal of clinical pharmacology, 2003, Volume: 59, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Middle Aged; Physicians; Sulfonylurea Compounds; Surveys and Questionnaires; Time Factors; Treatment Outcome	2003
Comparison of the effects of glimepiride and glibenclamide on adipose tissue tumour necrosis factor-alpha mRNA expression and cellularity. Diabetes, obesity & metabolism, 2004, Volume: 6, Issue:1 Topics: Adipose Tissue; Animals; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Gene Expression Regulation; Glyburide; Hypoglycemic Agents; Male; Obesity; Rats; Rats, Inbred OLETF; RNA, Messenger; Sulfonylurea Compounds; Tumor Necrosis Factor-alpha	2004
Metformin attenuates progression of carotid arterial wall thickness in patients with type 2 diabetes. Diabetes research and clinical practice, 2004, Volume: 64, Issue:3 Topics: Arteriosclerosis; Carotid Arteries; Carotid Artery Diseases; Chronic Disease; Diabetes Mellitus, Type 2; Diet Therapy; Drug Administration Schedule; Female; Gliclazide; Glyburide; Glycated Hemoglobin; Humans; Japan; Male; Metformin; Middle Aged; Prospective Studies; Sulfonylurea Compounds; Time Factors; Tunica Intima; Tunica Media	2004
Sulfonylurea agents exhibit peroxisome proliferator-activated receptor gamma agonistic activity. The Journal of biological chemistry, 2005, Jun-24, Volume: 280, Issue:25 Topics: 3T3-L1 Cells; Animals; Base Sequence; Cell Line; DNA Primers; Glyburide; Humans; Mice; PPAR gamma; Sulfonylurea Compounds	2005
Association between CYP2C9 slow metabolizer genotypes and severe hypoglycaemia on medication with sulphonylurea hypoglycaemic agents. British journal of clinical pharmacology, 2005, Volume: 60, Issue:1 Topics: Aged; Aryl Hydrocarbon Hydroxylases; Case-Control Studies; Cytochrome P-450 CYP2C9; Diabetes Mellitus, Type 2; Genotype; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Sulfonylurea Compounds	2005
Glimepiride induces nitric oxide production in human coronary artery endothelial cells via a PI3-kinase-Akt dependent pathway. Atherosclerosis, 2005, Volume: 183, Issue:1 Topics: Cells, Cultured; Chromones; Coronary Vessels; Endothelial Cells; Endothelium, Vascular; Enzyme Activation; Glyburide; Humans; Hypoglycemic Agents; Morpholines; Nitric Oxide; Oligodeoxyribonucleotides, Antisense; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Signal Transduction; Sulfonylurea Compounds	2005
[Hardly any hypoglycemias, constant weight--and still cost effective]. MMW Fortschritte der Medizin, 2005, Nov-24, Volume: 147, Issue:47 Topics: Body Weight; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Drugs, Generic; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin Resistance; Sulfonylurea Compounds	2005
Effects of mitiglinide and sulfonylureas in isolated canine coronary arteries and perfused rat hearts. European journal of pharmacology, 2006, Feb-15, Volume: 531, Issue:1-3 Topics: Animals; Coronary Circulation; Coronary Vessels; Cromakalim; Dogs; Dose-Response Relationship, Drug; Glyburide; Heart; Hypoglycemic Agents; In Vitro Techniques; Indoles; Isoindoles; Male; Myocardial Reperfusion Injury; Perfusion; Rats; Rats, Wistar; Sulfonylurea Compounds; Time Factors; Vasodilation; Vasodilator Agents	2006
Effects of mitiglinide on glucose-induced insulin release into the portal vein and fat-induced triglyceride elevation in prediabetic and diabetic OLETF rats. Endocrine, 2006, Volume: 29, Issue:2 Topics: Adipose Tissue; Animals; Blood Glucose; Cyclohexanes; Diabetes Mellitus, Type 2; Glucose Tolerance Test; Glyburide; Indoles; Insulin; Insulin Secretion; Isoindoles; Lipoprotein Lipase; Male; Nateglinide; Phenylalanine; Portal Vein; Postprandial Period; Prediabetic State; Rats; Rats, Inbred OLETF; RNA, Messenger; Sulfonylurea Compounds; Triglycerides	2006
Fast HPLC method for the determination of glimepiride, glibenclamide, and related substances using monolithic column and flow program. Journal of separation science, 2006, Volume: 29, Issue:11 Topics: Chromatography, High Pressure Liquid; Drug Stability; Glyburide; Hypoglycemic Agents; Reference Standards; Sulfonylurea Compounds	2006
Effect of glimepiride and glibenclamide on S-warfarin 7-hydroxylation by human liver microsomes, recombinant human CYP2C9.1 and CYP2C9.3. Biological & pharmaceutical bulletin, 2006, Volume: 29, Issue:9 Topics: Aryl Hydrocarbon Hydroxylases; Cell Survival; Cytochrome P-450 CYP2C9; Glyburide; Humans; Hydroxylation; Microsomes, Liver; Recombinant Proteins; Sulfonylurea Compounds; Warfarin	2006
Evaluation of monolithic HPLC columns for various pharmaceutical separations: method transfer from conventional phases and batch to batch repeatability. Journal of pharmaceutical and biomedical analysis, 2007, May-09, Volume: 44, Issue:1 Topics: Adrenergic beta-Antagonists; Buffers; Chromatography, High Pressure Liquid; Excipients; Glyburide; Hydrogen-Ion Concentration; Hypoglycemic Agents; Insulin; Ophthalmic Solutions; Pharmaceutical Preparations; Pilocarpine; Propranolol; Reference Standards; Reproducibility of Results; Solvents; Sulfonylurea Compounds; Time Factors	2007
Development of a RP-HPLC method for screening potentially counterfeit anti-diabetic drugs. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007, Jun-15, Volume: 853, Issue:1-2 Topics: Carbamates; Chromatography, High Pressure Liquid; Gliclazide; Glipizide; Glyburide; Hypoglycemic Agents; Molecular Structure; Piperidines; Reproducibility of Results; Sulfonylurea Compounds	2007
Comparisons between the beneficial effects of different sulphonylurea treatments on ischemia-induced retinal neovascularization. Free radical biology & medicine, 2007, Aug-01, Volume: 43, Issue:3 Topics: Acetylcysteine; Animals; Blood Glucose; Female; Gliclazide; Glyburide; Ischemia; Mice; Oxidative Stress; Oxygen; Retina; Retinal Neovascularization; RNA, Messenger; Sulfonylurea Compounds; Vascular Endothelial Growth Factor A	2007
A rapid and highly sensitive method for the determination of glimepiride in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a pre-clinical pharmacokinetic study. Biomedical chromatography : BMC, 2008, Volume: 22, Issue:1 Topics: Acetates; Acetonitriles; Administration, Oral; Animals; Chemical Fractionation; Chromatography, High Pressure Liquid; Glyburide; Humans; Hydrophobic and Hydrophilic Interactions; Hypoglycemic Agents; Male; Methanol; Molecular Structure; Rats; Rats, Wistar; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Sulfonylurea Compounds; Tandem Mass Spectrometry	2008
Polymorphonuclear leukocyte function in type-2 diabetes mellitus patients and its correlation with glycaemic control. Nepal Medical College journal : NMCJ, 2007, Volume: 9, Issue:2 Topics: Adult; Aged; Blood Glucose; Chronic Disease; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Glyburide; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Immunity, Cellular; Male; Middle Aged; Neutrophils; Respiratory Burst; Sulfonylurea Compounds	2007
Effects of glibenclamide, glimepiride, and gliclazide on ischemic preconditioning in rat heart. Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih, 2007, Volume: 22, Issue:3 Topics: Animals; Gliclazide; Glyburide; Heart; Ischemic Preconditioning; Male; Rats; Rats, Sprague-Dawley; Sulfonylurea Compounds	2007
Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France. Diabetes, obesity & metabolism, 2008, Volume: 10 Suppl 1 Topics: Cross-Sectional Studies; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; France; Glipizide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Metformin; Middle Aged; Quality of Life; Stress, Psychological; Sulfonylurea Compounds	2008
Repeatability of monolithic HPLC columns while using a flow program. Journal of separation science, 2008, Volume: 31, Issue:10 Topics: Area Under Curve; Chemistry, Pharmaceutical; Chromatography; Chromatography, High Pressure Liquid; Drug Stability; Glyburide; Hypoglycemic Agents; Models, Chemical; Reference Standards; Reproducibility of Results; Solvents; Sulfonylurea Compounds; Technology, Pharmaceutical; Time Factors	2008
Glimepiride upregulates eNOS activity and inhibits cytokine-induced NF-kappaB activation through a phosphoinoside 3-kinase-Akt-dependent pathway. Diabetes, obesity & metabolism, 2009, Volume: 11, Issue:2 Topics: Blotting, Western; Cells, Cultured; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelial Cells; Glyburide; Humans; Hypoglycemic Agents; NF-kappa B; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Sulfonylurea Compounds; Tumor Necrosis Factor-alpha; Up-Regulation	2009
Differential effect of sulfonylureas on production of reactive oxygen species and apoptosis in cultured pancreatic beta-cell line, MIN6. Metabolism: clinical and experimental, 2008, Volume: 57, Issue:8 Topics: Animals; Apoptosis; Cell Line; Cyclohexanes; Fluoresceins; Gliclazide; Glyburide; Hypoglycemic Agents; In Situ Nick-End Labeling; Insulin-Secreting Cells; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; NADPH Oxidases; Nateglinide; Phenylalanine; Protein Kinase C; Reactive Oxygen Species; Sulfonylurea Compounds	2008
SUR receptor activity vs. incidence of hypoglycaemia and cardiovascular mortality with sulphonylurea therapy for diabetics. Diabetes, obesity & metabolism, 2008, Volume: 10, Issue:11 Topics: ATP-Binding Cassette Transporters; Diabetes Mellitus; Glyburide; Humans; Hypoglycemia; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Sulfonylurea Compounds; Sulfonylurea Receptors	2008
Oral glyburide, but not glimepiride, blocks the infarct-size limiting effects of pioglitazone. Cardiovascular drugs and therapy, 2008, Volume: 22, Issue:6 Topics: Administration, Oral; Animals; Body Weight; Coronary Vessels; Data Interpretation, Statistical; Decanoic Acids; Diabetes Mellitus; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Glyburide; Hydroxy Acids; Injections, Intravenous; Intubation, Gastrointestinal; KATP Channels; Ligation; Mitochondria, Heart; Myocardial Infarction; Myocardial Ischemia; Pioglitazone; Rats; Rats, Sprague-Dawley; Sulfonylurea Compounds; Thiazolidinediones; Ventricular Remodeling	2008
Second-generation sulfonylureas preserve inhibition of mitochondrial permeability transition by the mitochondrial K+(ATP) opener nicorandil in experimental myocardial infarction. Shock (Augusta, Ga.), 2009, Volume: 32, Issue:3 Topics: Animals; Calcium; Gliclazide; Glyburide; Hemodynamics; Male; Mitochondria; Myocardial Infarction; Nicorandil; Potassium Channel Blockers; Potassium Channels; Rabbits; Sulfonylurea Compounds	2009
Glibenclamide-related excess in total and cardiovascular mortality risks: data from large Ukrainian observational cohort study. Diabetes research and clinical practice, 2009, Volume: 86, Issue:3 Topics: Blood Glucose; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cohort Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Middle Aged; Patient Selection; Proportional Hazards Models; Risk Factors; Sulfonylurea Compounds; Ukraine	2009
Comparison of ultraviolet detection, evaporative light scattering detection and charged aerosol detection methods for liquid-chromatographic determination of anti-diabetic drugs. Journal of pharmaceutical and biomedical analysis, 2010, Mar-11, Volume: 51, Issue:4 Topics: Aerosols; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Gliclazide; Glipizide; Glyburide; Hypoglycemic Agents; Light; Reproducibility of Results; Scattering, Radiation; Spectrophotometry, Ultraviolet; Sulfonylurea Compounds	2010
Effects of Glimepiride on metabolic parameters and cardiovascular risk factors in patients with newly diagnosed type 2 diabetes mellitus. Diabetes research and clinical practice, 2010, Volume: 88, Issue:1 Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin Resistance; Lipids; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Risk Factors; Sulfonylurea Compounds; Tissue Plasminogen Activator; Treatment Outcome	2010
Present status of sulfonylurea treatment for type 2 diabetes in Japan: second report of a cross-sectional survey of 15,652 patients. Endocrine journal, 2010, Volume: 57, Issue:6 Topics: Aged; Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Family Practice; Gliclazide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Japan; Middle Aged; Practice Patterns, Physicians'; Sulfonylurea Compounds; Treatment Outcome	2010
The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis. Diabetes care, 2010, Volume: 33, Issue:6 Topics: Aged; Diabetes Mellitus, Type 2; Female; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Sulfonylurea Compounds	2010
Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients. Expert opinion on drug safety, 2010, Volume: 9, Issue:5 Topics: Age Factors; Aged; Aged, 80 and over; Blood Glucose Self-Monitoring; Comorbidity; Diabetes Mellitus, Type 2; Female; Germany; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Inappropriate Prescribing; Incidence; Independent Living; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; Nursing Homes; Patient Education as Topic; Prospective Studies; Sulfonylurea Compounds	2010
The differentiating effect of glimepiride and glibenclamide on paraoxonase 1 and platelet-activating factor acetylohydrolase activity. Life sciences, 2010, Jul-17, Volume: 87, Issue:3-4 Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Antioxidants; Aryldialkylphosphatase; Diabetes Mellitus, Experimental; Glyburide; Hypoglycemic Agents; Lipid Peroxidation; Liver; Male; Rats; Rats, Wistar; Spectrophotometry; Streptozocin; Sulfonylurea Compounds	2010
Potential CYP2C9-mediated drug-drug interactions in hospitalized type 2 diabetes mellitus patients treated with the sulphonylureas glibenclamide, glimepiride or glipizide. Journal of internal medicine, 2010, Volume: 268, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C9; Diabetes Mellitus, Type 2; Drug Interactions; Female; Glipizide; Glyburide; Hospitalization; Humans; Hypoglycemic Agents; Male; Middle Aged; Sulfonylurea Compounds; Young Adult	2010
Effects of glimepiride and glibenclamide on carotid atherosclerosis in type 2 diabetic patients. Diabetes research and clinical practice, 2011, Volume: 92, Issue:1 Topics: Aged; Carotid Artery Diseases; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hypoglycemic Agents; Male; Middle Aged; Sulfonylurea Compounds; Treatment Outcome	2011
Postconditioning protects against human endothelial ischaemia-reperfusion injury via subtype-specific KATP channel activation and is mimicked by inhibition of the mitochondrial permeability transition pore. European heart journal, 2011, Volume: 32, Issue:10 Topics: Acetylcholine; Adult; Analysis of Variance; Brachial Artery; Cyclosporine; Endothelium, Vascular; Female; Forearm; Glyburide; Humans; Hyperemia; Ischemic Postconditioning; KATP Channels; Ligation; Male; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Reperfusion Injury; Sulfonylurea Compounds; Vascular Resistance; Vasodilation; Vasodilator Agents; Young Adult	2011
Antidiabetic sulfonylureas modulate farnesoid X receptor activation and target gene transcription. Future medicinal chemistry, 2010, Volume: 2, Issue:4 Topics: Animals; Chlorocebus aethiops; COS Cells; Genes, Reporter; Glyburide; Hep G2 Cells; Humans; Hypoglycemic Agents; Models, Molecular; Molecular Dynamics Simulation; Protein Conformation; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Sulfonylurea Compounds; Transcriptional Activation	2010
Glitazone-like action of glimepiride and glibenclamide in primary human adipocytes. Diabetes, obesity & metabolism, 2011, Volume: 13, Issue:9 Topics: Adipocytes; Cell Differentiation; Cells, Cultured; Gene Expression; Glyburide; Humans; Lipid Metabolism; Polymerase Chain Reaction; Sulfonylurea Compounds; Thiazolidinediones; Triglycerides	2011
Comparable long-term mortality risk associated with individual sulfonylureas in diabetes patients with heart failure. Diabetes research and clinical practice, 2011, Volume: 94, Issue:1 Topics: Aged; Aged, 80 and over; Diabetes Mellitus; Female; Glipizide; Glyburide; Heart Failure; Humans; Hypoglycemic Agents; Male; Sulfonylurea Compounds; Tolbutamide	2011
Hypoglycemia after accidental pediatric sulfonylurea ingestions. Pediatric emergency care, 2011, Volume: 27, Issue:9 Topics: Accidents, Home; Arizona; Blood Glucose; Child, Preschool; Emergency Service, Hospital; Glipizide; Glucose; Glyburide; Hospitals, Pediatric; Hospitals, Teaching; Hospitals, Urban; Humans; Hypoglycemia; Hypoglycemic Agents; Incidence; Infant; Poisoning; Retrospective Studies; Sulfonylurea Compounds; Time Factors	2011
CYP105A1 mediated 3-hydroxylation of glimepiride and glibenclamide using a recombinant Bacillus megaterium whole-cell catalyst. Journal of biotechnology, 2012, Feb-10, Volume: 157, Issue:3 Topics: Bacillus megaterium; Bacterial Proteins; Blotting, Western; Catalysis; Cytochrome P-450 Enzyme System; DNA Primers; Electrophoresis, Polyacrylamide Gel; Ferredoxin-NADP Reductase; Ferredoxins; Glyburide; Hydroxylation; Kinetics; Magnetic Resonance Spectroscopy; Membrane Proteins; Oxygenases; Plasmids; Schizosaccharomyces; Schizosaccharomyces pombe Proteins; Sulfonylurea Compounds	2012
Pharmacogenomic analysis of ATP-sensitive potassium channels coexpressing the common type 2 diabetes risk variants E23K and S1369A. Pharmacogenetics and genomics, 2012, Volume: 22, Issue:3 Topics: ATP-Binding Cassette Transporters; Chlorpropamide; Cyclohexanes; Diabetes Mellitus, Type 2; Gene Expression Regulation; Gliclazide; Glyburide; Haplotypes; Homozygote; Humans; Isoindoles; Nateglinide; Patch-Clamp Techniques; Phenylalanine; Polymorphism, Single Nucleotide; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Structure-Activity Relationship; Sulfonylurea Compounds; Sulfonylurea Receptors; Tolbutamide	2012
The risk of overall mortality in patients with Type 2 diabetes receiving different combinations of sulfonylureas and metformin: a retrospective analysis. Diabetic medicine : a journal of the British Diabetic Association, 2012, Volume: 29, Issue:8 Topics: Aged; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Retrospective Studies; Risk Factors; Sulfonylurea Compounds	2012
Increase in overall mortality risk in patients with type 2 diabetes receiving glipizide, glyburide or glimepiride monotherapy versus metformin: a retrospective analysis. Diabetes, obesity & metabolism, 2012, Volume: 14, Issue:9 Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Kaplan-Meier Estimate; Male; Metformin; Middle Aged; Propensity Score; Retrospective Studies; Sulfonylurea Compounds; Young Adult	2012
Gene networks modified by sulphonylureas in beta cells: a pathway-based analysis of insulin secretion and cell death. Basic & clinical pharmacology & toxicology, 2012, Volume: 111, Issue:4 Topics: Animals; Cell Death; Cell Line; Cluster Analysis; Diabetes Mellitus, Type 2; Gene Regulatory Networks; Gliclazide; Glyburide; Hypoglycemic Agents; Insulin; Insulin Secretion; Insulin-Secreting Cells; Microarray Analysis; Rats; Sulfonylurea Compounds; Up-Regulation	2012
Treatment persistence, hypoglycaemia and clinical outcomes in type 2 diabetes patients with dipeptidyl peptidase-4 inhibitors and sulphonylureas: a primary care database analysis. Diabetes, obesity & metabolism, 2013, Volume: 15, Issue:1 Topics: Blood Glucose; Databases, Factual; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Female; Germany; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Medication Adherence; Metformin; Middle Aged; Primary Health Care; Retrospective Studies; Sulfonylurea Compounds	2013
Effects of a sitagliptin safety alert on prescription behaviour for oral antihyperglycaemic drugs: a propensity score-matched cohort study of prescription receipt data in Japan. Drug safety, 2013, Volume: 36, Issue:8 Topics: Aged; Cohort Studies; Female; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Japan; Logistic Models; Male; Middle Aged; Patient Safety; Practice Patterns, Physicians'; Propensity Score; Pyrazines; Sitagliptin Phosphate; Sulfonylurea Compounds; Triazoles	2013
Inflammation and cognitive dysfunction in type 2 diabetic carotid endarterectomy patients. Diabetes care, 2013, Volume: 36, Issue:10 Topics: Aged; Cognition Disorders; Diabetes Mellitus, Type 2; Endarterectomy, Carotid; Glyburide; Humans; Hypoglycemic Agents; Inflammation; Logistic Models; Metformin; Middle Aged; Pyrazines; Sitagliptin Phosphate; Sulfonylurea Compounds; Triazoles	2013
Oral hypoglycaemic agents and the development of non-fatal cardiovascular events in patients with type 2 diabetes mellitus. Diabetes/metabolism research and reviews, 2013, Volume: 29, Issue:8 Topics: Administration, Oral; Adult; Aged; Cardiovascular Diseases; Cohort Studies; Comorbidity; Coronary Disease; Diabetes Mellitus, Type 2; Dyslipidemias; Female; Glyburide; Humans; Hypertension; Hypoglycemic Agents; Incidence; Male; Metformin; Middle Aged; Retrospective Studies; Sulfonylurea Compounds; Taiwan	2013
Metformin in combination with various insulin secretagogues in type 2 diabetes and associated risk of cardiovascular morbidity and mortality--a retrospective nationwide study. Diabetes research and clinical practice, 2015, Volume: 107, Issue:1 Topics: Aged; Carbamates; Cardiovascular Diseases; Denmark; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Morbidity; Myocardial Infarction; Piperidines; Registries; Retrospective Studies; Risk Factors; Stroke; Sulfonylurea Compounds; Tolbutamide	2015
Severe hypoglycemia in users of sulfonylurea antidiabetic agents and antihyperlipidemics. Clinical pharmacology and therapeutics, 2016, Volume: 99, Issue:5 Topics: Aged; Algorithms; Cohort Studies; Drug Interactions; Female; Fenofibrate; Glipizide; Glyburide; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypolipidemic Agents; Incidence; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Sulfonylurea Compounds	2016
Fasiglifam/TAK-875, a Selective GPR40 Agonist, Improves Hyperglycemia in Rats Unresponsive to Sulfonylureas and Acts Additively with Sulfonylureas. The Journal of pharmacology and experimental therapeutics, 2016, Volume: 357, Issue:1 Topics: Animals; Benzofurans; Blood Glucose; Diabetes Mellitus, Experimental; Drug Synergism; Glucose Tolerance Test; Glyburide; Hyperglycemia; Hypoglycemic Agents; Male; Rats; Rats, Zucker; Receptors, G-Protein-Coupled; Sulfones; Sulfonylurea Compounds	2016
Evaluation, efficacy and tolerability of GlucoNovax tablet in type 2 diabetic patients. Pakistan journal of pharmaceutical sciences, 2016, Volume: 29, Issue:4 Suppl Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glyburide; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Quality of Life; Sulfonylurea Compounds; Tablets; Treatment Outcome	2016
Biomedical Informatics Approaches to Identifying Drug-Drug Interactions: Application to Insulin Secretagogues. Epidemiology (Cambridge, Mass.), 2017, Volume: 28, Issue:3 Topics: Area Under Curve; Carbamates; Cyclohexanes; Databases, Factual; Diabetes Mellitus, Type 2; Drug Interactions; Glipizide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Medical Informatics; Nateglinide; Pharmacoepidemiology; Phenylalanine; Piperidines; Sulfonylurea Compounds	2017
Implementation and Assessment of an Ambulatory Prescribing Guidance Tool to Improve Patient Safety in the Geriatric Population. The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2017, Mar-01, Volume: 32, Issue:3 Topics: Aged; Ambulatory Care; Decision Support Systems, Clinical; Diabetes Mellitus; Drug Interactions; Glyburide; Humans; Hypoglycemic Agents; Medication Errors; Patient Safety; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prescription Drug Misuse; Sulfonylurea Compounds	2017
Comparative Safety of Sulfonylureas and the Risk of Sudden Cardiac Arrest and Ventricular Arrhythmia. Diabetes care, 2018, Volume: 41, Issue:4 Topics: Aged; Arrhythmias, Cardiac; Cause of Death; Death, Sudden, Cardiac; Diabetic Angiopathies; Female; Glipizide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Middle Aged; Retrospective Studies; Risk Factors; Sulfonylurea Compounds; United States; Ventricular Dysfunction	2018
Different sulfonylureas induce the apoptosis of proximal tubular epithelial cell differently via closing K Molecular medicine (Cambridge, Mass.), 2018, 09-04, Volume: 24, Issue:1 Topics: Apoptosis; Cell Line; Epithelial Cells; Gliclazide; Glyburide; Humans; KATP Channels; Kidney Tubules, Proximal; Sulfonylurea Compounds	2018
Comparison of mortality and cardiovascular event risk associated with various insulin secretagogues: A nationwide real-world analysis. Diabetes research and clinical practice, 2019, Volume: 152 Topics: Aged; Carbamates; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Follow-Up Studies; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Middle Aged; Mortality; Piperidines; Secretagogues; Sulfonylurea Compounds; Taiwan	2019
Risk of sudden cardiac arrest and ventricular arrhythmia with sulfonylureas: An experience with conceptual replication in two independent populations. Scientific reports, 2020, 06-22, Volume: 10, Issue:1 Topics: Aged; Cohort Studies; Death, Sudden, Cardiac; Diabetes Mellitus, Type 2; Female; Glipizide; Glyburide; Humans; Male; Medicaid; Middle Aged; Sulfonylurea Compounds; Treatment Outcome; United States; Ventricular Fibrillation	2020
Sensitive detection of antidiabetic compounds and one degradation product in wastewater samples by a new SPE-LC-MS/MS method. Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering, 2021, Volume: 56, Issue:3 Topics: Chromatography, Liquid; Environmental Monitoring; Gliclazide; Glipizide; Glyburide; Hypoglycemic Agents; Metformin; Reproducibility of Results; Solid Phase Extraction; Sulfonylurea Compounds; Tandem Mass Spectrometry; Wastewater; Water Pollutants, Chemical	2021
Angiotensin-Converting Enzyme Inhibitors Used Concomitantly with Insulin Secretagogues and the Risk of Serious Hypoglycemia. Clinical pharmacology and therapeutics, 2022, Volume: 111, Issue:1 Topics: Administrative Claims, Healthcare; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Carbamates; Databases, Factual; Diabetes Mellitus, Type 2; Drug Interactions; Female; Glipizide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Medicaid; Metformin; Middle Aged; Nateglinide; Pharmacoepidemiology; Piperidines; Secretagogues; Sulfonylurea Compounds; United States	2022
Comparative safety of sulfonylureas among U.S. nursing home residents. Journal of the American Geriatrics Society, 2023, Volume: 71, Issue:4 Topics: Aged; Female; Glipizide; Glyburide; Humans; Hypoglycemia; Male; Medicare; Myocardial Infarction; Nursing Homes; Retrospective Studies; Stroke; United States	2023
Analytical Method Capable of Quantifying Eight Nitrosamine Impurities from Five Different Commercially Available Metformin Formulations with Glipizide, Glibenclamide, Gliclazide, Evogliptin, and Glimepiride by Ultra High Performance Liquid Chromatography Journal of pharmaceutical sciences, 2023, Volume: 112, Issue:5 Topics: Chromatography, High Pressure Liquid; Chromatography, Liquid; Diabetes Mellitus, Type 2; Gliclazide; Glipizide; Glyburide; Humans; Metformin; Nitrosamines; Pharmaceutical Preparations; Tandem Mass Spectrometry	2023
Analysis of Hypoglycemic Drugs by Liquid Chromatography-Tandem Mass Spectrometry. Methods in molecular biology (Clifton, N.J.), 2024, Volume: 2737 Topics: Chlorpropamide; Chromatography, High Pressure Liquid; Chromatography, Liquid; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Nateglinide; Pioglitazone; Rosiglitazone; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Tolazamide; Tolbutamide	2024